Generation Bio Co. (GBIO)

Generation Bio Co. Statistics

Total Valuation

GBIO has a market cap or net worth of $28.62 million. The enterprise value is -$63.04 million.

Market Cap	28.62M
Enterprise Value	-63.04M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

GBIO has 67.01 million shares outstanding. The number of shares has increased by 3.32% in one year.

Current Share Class	67.01M
Shares Outstanding	67.01M
Shares Change (YoY)	+3.32%
Shares Change (QoQ)	+0.08%
Owned by Insiders (%)	5.56%
Owned by Institutions (%)	69.24%
Float	49.15M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.43
Forward PS	4.00
PB Ratio	0.33
P/TBV Ratio	0.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.50, with a Debt / Equity ratio of 1.09.

Current Ratio	5.50
Quick Ratio	5.33
Debt / Equity	1.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.02% and return on invested capital (ROIC) is -20.59%.

Return on Equity (ROE)	-91.02%
Return on Assets (ROA)	-16.34%
Return on Invested Capital (ROIC)	-20.59%
Return on Capital Employed (ROCE)	-40.38%
Revenue Per Employee	$172,974
Profits Per Employee	-$1.14M
Employee Count	115
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.62% in the last 52 weeks. The beta is 2.78, so GBIO's price volatility has been higher than the market average.

Beta (5Y)	2.78
52-Week Price Change	-85.62%
50-Day Moving Average	0.49
200-Day Moving Average	1.59
Relative Strength Index (RSI)	49.36
Average Volume (20 Days)	586,733

Short Selling Information

The latest short interest is 1.67 million, so 2.50% of the outstanding shares have been sold short.

Short Interest	1.67M
Short Previous Month	1.69M
Short % of Shares Out	2.50%
Short % of Float	3.40%
Short Ratio (days to cover)	3.04

Income Statement

In the last 12 months, GBIO had revenue of $19.89 million and -$131.67 million in losses. Loss per share was -$1.98.

Revenue	19.89M
Gross Profit	-27.88M
Operating Income	-79.19M
Pretax Income	-158.43M
Net Income	-131.67M
EBITDA	-74.26M
EBIT	-79.19M
Loss Per Share	-$1.98

Balance Sheet

The company has $185.22 million in cash and $93.56 million in debt, giving a net cash position of $91.66 million or $1.37 per share.

Cash & Cash Equivalents	185.22M
Total Debt	93.56M
Net Cash	91.66M
Net Cash Per Share	$1.37
Equity (Book Value)	86.20M
Book Value Per Share	1.29
Working Capital	157.85M

Cash Flow

In the last 12 months, operating cash flow was -$88.56 million and capital expenditures -$2.40 million, giving a free cash flow of -$90.96 million.

Operating Cash Flow	-88.56M
Capital Expenditures	-2.40M
Free Cash Flow	-90.96M
FCF Per Share	-$1.36

Margins

Gross Margin	-140.16%
Operating Margin	-398.11%
Pretax Margin	-661.91%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.32%
Shareholder Yield	n/a
Earnings Yield	-460.03%
FCF Yield	-317.82%

Analyst Forecast

The average price target for GBIO is $7.33, which is 1,616.23% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.33
Price Target Difference	1,616.23%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	9.66%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GBIO has an Altman Z-Score of -3.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.79
Piotroski F-Score	3